Immediate Impact
2 standout
Citing Papers
CAR T therapies in multiple myeloma: unleashing the future
2024 Standout
Liquid biopsy in cancer: current status, challenges and future prospects
2024 Standout
Works of Christoph Mann being referenced
Monitoring multiple myeloma in the peripheral blood based on cell-free DNA and circulating plasma cells
2022
Isatuximab, Carfilzomib, Lenalidomide and Dexamethasone (I-KRd) in front-line treatment of high-risk Multiple Myeloma: Results of the Safety Run-In cohort in the phase II, multicenter GMMG-CONCEPT trial
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Christoph Mann | 38 | 34 | 1 | 29 | 10 | 50 | |
| Raphael Lutz | 36 | 31 | 22 | 11 | 48 | ||
| Titouan Cazaubiel | 47 | 37 | 1 | 31 | 11 | 60 | |
| Marianne Huben | 22 | 17 | 4 | 27 | 11 | 54 | |
| Tania Tan | 28 | 113 | 3 | 31 | 8 | 167 | |
| Samuel M. Rubinstein | 9 | 15 | 41 | 10 | 65 | ||
| Emma Logan | 24 | 35 | 58 | 10 | 71 | ||
| Dinesh Kumar Sinha | 22 | 24 | 16 | 26 | 11 | 54 | |
| Geoffrey Fell | 12 | 22 | 1 | 19 | 10 | 63 | |
| Karin H. Herbschleb | 44 | 120 | 2 | 74 | 10 | 164 | |
| Poorvi Somaiya | 86 | 72 | 1 | 112 | 11 | 195 |
All Works
Login with ORCID to disown or claim papers
Loading papers...